StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Regenerative Medical Technology's operating cash flow for the twelve months ending Jun 30, 2026 was $268.56K, up 141.2% year over year. For fiscal 2025 it was -$706.52K, down 183.1% from the year before. The highest annual figure on record is $850.70K in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$706.52K-183.1%
FY2024Dec 31, 2024$850.70K–
FY2023Dec 31, 2023-$419.20K–
FY2022Dec 31, 2022-$1.11M–
FY2021Dec 31, 2021-$9.88M–
FY2020Dec 31, 2020-$322.75K–
FY2019Dec 31, 2019-$362.33K–
FY2018Dec 31, 2018-$244.64K–
FY2017Dec 31, 2017-$6.12K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$331.97K–
Q1 FY2026Mar 31, 2026$102.12K+78.8%
Q4 FY2025Dec 31, 2025$38.20K-89.9%
Q3 FY2025Sep 30, 2025-$203.73K-174.6%
Q2 FY2025Jun 30, 2025-$598.09K-761.6%
Q1 FY2025Mar 31, 2025$57.11K-47.1%
Q4 FY2024Dec 31, 2024$379.39K–
Q3 FY2024Sep 30, 2024$272.94K+2592.3%
Q2 FY2024Jun 30, 2024$90.40K–
Q1 FY2024Mar 31, 2024$107.97K+1493.6%
Q4 FY2023Dec 31, 2023-$29.40K–
Q3 FY2023Sep 30, 2023$10.14K–
Q2 FY2023Jun 30, 2023-$406.71K–
Q1 FY2023Mar 31, 2023$6.78K–
Q4 FY2022Dec 31, 2022-$49.43K–
Q3 FY2022Sep 30, 2022-$152.18K–
Q2 FY2022Jun 30, 2022-$396.43K–
Q1 FY2022Mar 31, 2022-$516.11K–
Q4 FY2021Dec 31, 2021-$8.75M–
Q3 FY2021Sep 30, 2021-$430.66K–
Q2 FY2021Jun 30, 2021-$544.31K–
Q1 FY2021Mar 31, 2021-$154.86K–
Q4 FY2020Dec 31, 2020-$96.94K–
Q3 FY2020Sep 30, 2020-$92.10K–
Q2 FY2020Jun 30, 2020-$69.03K–
Q1 FY2020Mar 31, 2020-$64.68K–
Q4 FY2019Dec 31, 2019-$48.45K–
Q3 FY2019Sep 30, 2019-$134.68K–
Q2 FY2019Jun 30, 2019-$86.57K–
Q1 FY2019Mar 31, 2019-$92.63K–
Q4 FY2018Dec 31, 2018-$73.87K–
Q3 FY2018Sep 30, 2018-$68.21K–
Q2 FY2018Jun 30, 2018-$67.63K–
Q1 FY2018Mar 31, 2018-$34.94K–

More Regenerative Medical Technology figures

See a number that looks wrong?